Regaining compliance with Nasdaq listing requirements typically removes the immediate risk of delisting, which can be a significant concern for investors. This news is likely to be viewed positively by the market, as it suggests that BioSig Technologies is addressing the issues that led to non-compliance and is taking steps to maintain its listing status. This can lead to increased investor confidence and potentially a short-term positive impact on the stock price.